论文部分内容阅读
毛细支气管炎是儿科常见的一种特殊类型肺炎,多见于2岁以内婴幼儿,特别是6个月以下婴儿。喘憋是本病最具特征性的表现,也是构成恶性循环和导致重症病例死亡的主要环节。迅速有效地控制喘憋,是获得本病治疗成功的关键。过去一般采用皮质激素、抗组织胺类药物、氨茶碱或复方冬眠灵等,近年还有人推荐莨菪硷类药物。这些药物均有一定的止喘作用,但有些药物却不同程度地存在一些副反应。我们从1983年11月7日至1984年10月4日应用维生素K_3(以下简称K_3)治疗毛细支气管炎86例,实践证明对控制喘憋疗效显著,现总结如下。
Bronchiolitis is a common pediatric pneumonia, more common in infants and young children less than 2 years of age, especially infants under 6 months. Asthma is the most characteristic manifestation of the disease, but also constitute a vicious circle and lead to death of major cases of major links. Rapid and effective control of wheezing is the key to successful treatment of this disease. In the past generally used corticosteroids, antihistamines, aminophylline or compound winter sleep Ling, etc., in recent years there are others recommended alkaloid drugs. These drugs have a certain anti-asthmatic effect, but some drugs to varying degrees, there are some side effects. We from November 7, 1983 to October 4, 1984 application of vitamin K_3 (hereinafter referred to as K_3) in the treatment of bronchiolitis in 86 cases, the practice proved effective in controlling wheezing, are summarized as follows.